ロード中...
Nephrolithiasis in topiramate users
Topiramate is a neuromodulatory agent increasingly prescribed for a number of neurological and non-neurological indications. Topiramate-treated patients are at risk for nephrolithiasis due to hypocitraturia and high urine pH. However, the prevalence of symptomatic stone disease in TPM users is gener...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4103417/ https://ncbi.nlm.nih.gov/pubmed/21165738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00240-010-0347-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|